Medicare Enrolled
Dr. Scott Sellinger, MD
Urology Physician · Tallahassee, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sellinger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sellinger?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sellinger
Dr. Scott Sellinger is an urology physician in Tallahassee, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sellinger performed 6,320 Medicare services across 1,525 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sellinger received a total of $2,045,547 from 63 pharmaceutical and/or device companies across 2720 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sellinger is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in FL
$2,045,547 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 51896 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗6,320
Medicare services
Top 19% in FL for urology physician
1,525
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~333 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,880 | $18 | $42 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,200 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
540 | $89 | $320 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
453 | $2 | $5 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 228 | $134 | $336 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
195 | $47 | $159 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
138 | $6 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $65 | $227 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
92 | $11 | $35 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
68 | $24 | $80 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
67 | $21 | $60 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
56 | $8 | $26 |
| Injection, garamycin, gentamicin, up to 80 mg | 44 | $2 | $3 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
36 | $78 | $209 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
33 | $3 | $6 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
28 | $64 | $207 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
24 | $42 | $156 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $77 | $283 |
| Simple change of bladder tube | 18 | $77 | $243 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $93 | $422 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
13 | $105 | $333 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
13 | $26 | $65 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
13 | $25 | $63 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
11 | $199 | $518 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,045,547
Total received (2018-2024)
Avg $292,221/year across 7 years
Top 0% in FL for urology physician
63
Companies
2,720
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,970,768 (96.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$65,238 (3.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,541 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$376,938
2023
$399,765
2022
$355,718
2021
$232,638
2020
$153,267
2019
$302,678
2018
$224,544
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$472,536
AstraZeneca Pharmaceuticals LP
$350,336
Astellas Pharma US Inc
$268,980
PFIZER INC.
$235,057
Bayer HealthCare Pharmaceuticals Inc.
$153,475
Janssen Scientific Affairs, LLC
$147,755
TOLMAR Pharmaceuticals, Inc.
$88,412
Myovant Sciences Inc.
$76,598
Bayer Healthcare Pharmaceuticals Inc.
$58,902
Sumitomo Pharma America, Inc.
$45,121
Dendreon Pharmaceuticals LLC
$21,381
Amgen Inc.
$20,791
Tolmar, Inc.
$16,637
Ferring Pharmaceuticals Inc.
$16,284
Merck Sharp & Dohme LLC
$14,466
Progenics Pharmaceuticals, Inc.
$9,587
Janssen Pharmaceuticals, Inc
$8,432
ACCORD HEALTHCARE, INC.
$6,005
Tempus AI, Inc
$5,089
AbbVie, Inc.
$3,863
UROGEN PHARMA, INC.
$3,356
Janssen Global Services, LLC
$3,282
UroGen Pharma, Inc.
$3,086
Pfizer Inc.
$2,961
NOVARTIS PHARMACEUTICALS CORPORATION
$2,100
Clovis Oncology, Inc.
$1,901
Novartis Pharmaceuticals Corporation
$1,861
Verity Pharmaceuticals Inc.
$1,335
E.R. Squibb & Sons, L.L.C.
$870
Myriad Genetic Laboratories, Inc.
$731
Boston Scientific Corporation
$503
Blue Earth Diagnostics Limited
$499
Allergan Inc.
$431
ABBVIE INC.
$340
Allergan, Inc.
$322
Endo Pharmaceuticals Inc.
$303
Medtronic, Inc.
$252
Antares Pharma, Inc.
$195
AbbVie Inc.
$173
KARL STORZ Endoscopy-America
$168
MEDIVATION FIELD SOLUTIONS LLC
$134
Cook Medical LLC
$100
PROCEPT BioRobotics Corporation
$94
Endo USA, Inc.
$92
Axonics Modulation Technologies, Inc.
$90
Merck Sharp & Dohme Corporation
$75
Avadel Specialty Pharmaceuticals, LLC
$72
Foundation Medicine, Inc.
$71
Axonics, Inc.
$63
UROVANT SCIENCES INC
$53
Rochester Medical Corporation
$42
Olympus America Inc.
$41
Coloplast Corp
$40
BOSTON SCIENTIFIC CORPORATION
$38
Laborie Medical Technologies Corp.
$31
MIMEDX Group, Inc.
$20
COLOPLAST CORP
$20
PROGENICS PHARMACEUTICALS, INC.
$18
DAVOL INC.
$17
Telix Pharmaceuticals
$16
Retrophin, Inc.
$15
Clarus Therapeutics Inc.
$13
Medtronic USA, Inc.
$12
Top 3 companies account for 53.4% of total payments
Associated products mentioned in payments ›
(815) Thiola · 8.5 FR. X 675MM · ADSTILADRIN · AKEEGA · AMS · AMS 700 · AQUABEAM SYSTEM · ARISTA AH · ASCERTA · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CMOS VIDEO URETEROSCOPE · COOK · COOK MEDICAL HOLMIUM LASER FIBER · COOK MEDICAL LASERS · COOK MEDICAL PERC SETS · EDEX · ELIGARD · ERLEADA · EVENITY · Eclipse · EndoSheath Technology · Erleada · FIRMAGON · FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM · GEMTESA · GENERAL KIDNEY STONE DISEASE · HIWIRE · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LYNX · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Non-Covered · Nubeqa · ORGOVYX · PLUVICTO · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · RUBRACA · Rezum Generator · SPACEOAR · SPACEOAR VUE · SPIES CMOS VIDEO URETEROSCOPE · SUTENT · SpeediCath · TALZENNA · TITAN · TOVIAZ · Trelstar · VIAGRA · Veozah · XGEVA · XIAFLEX · XT CDX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for urology physician in FL.
Equivalent to $32,366 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
20
Per 100K population
6.8
County median income
$65,074
Nearest hospital
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sellinger is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), with speaking/promotional industry engagement in the top 0% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sellinger experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sellinger performed 2,880 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sellinger receive payments from pharmaceutical companies?
Yes. Dr. Sellinger received a total of $2,045,547 from 63 companies across 2,720 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sellinger's costs compare to other urology physicians in Tallahassee?
Dr. Sellinger's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sellinger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Tallahassee
Browse urology physicians in Tallahassee ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology